.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
US Army
McKinsey
Colorcon
Fuji
Mallinckrodt
Julphar
Cipla
Farmers Insurance
Fish and Richardson

Generated: June 24, 2017

DrugPatentWatch Database Preview

Doxazosin mesylate - Generic Drug Details

« Back to Dashboard

What are the generic sources for doxazosin mesylate and what is the scope of doxazosin mesylate freedom to operate?

Doxazosin mesylate
is the generic ingredient in three branded drugs marketed by Mylan, Nesher Pharms, Accord Hlthcare, Watson Labs Inc, Idt Australia Ltd, Teva, Sandoz, Pliva, Ivax Sub Teva Pharms, Dava Pharms Inc, Genpharm, Pfizer, Actavis Elizabeth, and Apotex, and is included in sixteen NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are thirteen drug master file entries for doxazosin mesylate. Thirty-four suppliers are listed for this compound.

Summary for Generic Name: doxazosin mesylate

Tradenames:3
Patents:1
Applicants:14
NDAs:16
Drug Master File Entries: see list13
Suppliers / Packagers: see list34
Bulk Api Vendors: see list59
Clinical Trials: see list556
Patent Applications: see list2,490
Therapeutic Class:Genitourinary Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:doxazosin mesylate at DailyMed

Pharmacology for Ingredient: doxazosin mesylate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Nesher Pharms
DOXAZOSIN MESYLATE
doxazosin mesylate
TABLET;ORAL075609-003Oct 18, 2000DISCNNoNo► Subscribe► Subscribe
Accord Hlthcare
DOXAZOSIN MESYLATE
doxazosin mesylate
TABLET;ORAL202824-003Jun 11, 2014ABRXNoNo► Subscribe► Subscribe
Sandoz
DOXAZOSIN MESYLATE
doxazosin mesylate
TABLET;ORAL075646-004Oct 18, 2000DISCNNoNo► Subscribe► Subscribe
Idt Australia Ltd
DOXAZOSIN MESYLATE
doxazosin mesylate
TABLET;ORAL075432-003Oct 18, 2000DISCNNoNo► Subscribe► Subscribe
Watson Labs Inc
DOXAZOSIN MESYLATE
doxazosin mesylate
TABLET;ORAL075426-004Oct 18, 2000DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: doxazosin mesylate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer
CARDURA
doxazosin mesylate
TABLET;ORAL019668-004Nov 2, 19904,188,390► Subscribe
Pfizer
CARDURA
doxazosin mesylate
TABLET;ORAL019668-001Nov 2, 19904,188,390► Subscribe
Pfizer
CARDURA XL
doxazosin mesylate
TABLET, EXTENDED RELEASE;ORAL021269-002Feb 22, 20054,837,111► Subscribe
Pfizer
CARDURA
doxazosin mesylate
TABLET;ORAL019668-003Nov 2, 19904,188,390► Subscribe
Pfizer
CARDURA
doxazosin mesylate
TABLET;ORAL019668-002Nov 2, 19904,188,390► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Cipla
AstraZeneca
Fuji
Accenture
Covington
Baxter
Boehringer Ingelheim
Cerilliant
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot